; entire record in Supplementary Table S4) to ascertain their mutational position in tumors of enrolled patients as a possible biomarker of therapeutic reaction. DNA was extracted from obtainable tumor samples (We utilized RNA-seq to check genome-wide gene expression in these PDXs for their client tumor of origin along with the expression profiles … Read More